Shares of Moderna Inc. climbed nearly 1% on Friday, reaching levels last seen on Jan. 10, as retail sentiment turned ...

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

The COVID-19 pandemic may have ended a long time ago, but the European Commission is still ordering 146 million doses of coronavirus vaccines, Berliner Zeitung reports. The costs, however, remain ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

Europe preventive vaccines market was valued at $18.02 billion ... rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure. Request To Download Free ...

Dr Meg Schaeffer, an epidemiologist at the SAS Institute, told AFP that “misinformation around Covid-19” was driving down ...

The effects of both Covid-19 infection and the Covid vaccine during pregnancy on developing foetuses is to be examined as part of a cross-border study. Infection and vaccine uptake data on pregnant ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

In September 2024, the European Commission (EC) granted marketing authorization for an updated formulation of Moderna's COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.